Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

560
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
560
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

485
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
485
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

440
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
440

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk of neuroblastoma among patients with pediatric Horner syndrome.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus·2026
Same author

Association between Dupilumab and Ocular Surface Diseases in Children.

Ophthalmology science·2026
Same author

Digital binocular surgical loupes for oculoplastic surgery using a three-dimensional digital camera and a virtual reality smart glasses: A pilot study.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society·2025
Same author

Effect of Acetazolamide on Intraocular Pressure After Uneventful Phacoemulsification Using an Anterior Chamber Maintainer.

Vision (Basel, Switzerland)·2025
Same author

Management strategies for chalazia in pediatric patients: A scoping review.

European journal of ophthalmology·2025
Same author

Postoperative Outcomes of Enucleation Without Closure of the Conjunctiva.

Ophthalmic plastic and reconstructive surgery·2024

Related Experiment Video

Updated: Jun 28, 2025

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.3K

Temozolomide-associated blepharoconjunctivitis: a case report.

Tom Kornhauser1, John D Pemberton2

  • 1Jones Eye Institute, University of Arkansas for Medical Sciences, 4301 W. Markham Street, 72207, Little Rock, AR, USA. tkornhauser@uams.edu.

BMC Ophthalmology
|April 12, 2024
PubMed
Summary
This summary is machine-generated.

Temozolomide (TMZ), a glioblastoma treatment, can cause blepharoconjunctivitis. This case report details a patient who developed eyelid and conjunctival inflammation after TMZ therapy, which resolved with treatment.

Area of Science:

  • Oncology
  • Ophthalmology
  • Pharmacology

Background:

  • Temozolomide (TMZ) is a key oral alkylating agent for glioblastoma multiforme (GBM) and high-grade gliomas.
Keywords:
BlepharitisBlepharoconjunctivitisCase reportGlioblastoma multiformeTemozolomide

More Related Videos

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

15.9K
A Reversible Silicon Oil-Induced Ocular Hypertension Model in Mice
09:03

A Reversible Silicon Oil-Induced Ocular Hypertension Model in Mice

Published on: November 15, 2019

9.9K

Related Experiment Videos

Last Updated: Jun 28, 2025

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.3K
A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

15.9K
A Reversible Silicon Oil-Induced Ocular Hypertension Model in Mice
09:03

A Reversible Silicon Oil-Induced Ocular Hypertension Model in Mice

Published on: November 15, 2019

9.9K
  • TMZ functions by methylating DNA, thereby inhibiting cellular proliferation.
  • This report documents a case of blepharoconjunctivitis associated with TMZ administration.